Baby Observational and Nutritional Study

Completed

Conditions studied: Cystic Fibrosis, Growth Failure, Exocrine Pancreatic Insufficiency

In brief

Cystic fibrosis (CF) is a life-shortening disease that causes breathing and digestive problems, but can now be diagnosed at the time of birth. Lung function is very hard to measure in infants, but growth is not. In this study the investigators aim to define growth in infants with CF in the first year of life with research quality precision and to understand factors that interfere with good growth. Pancreatic enzyme replacement therapy (PERT) will be also be studied in a subgroup of infants. Two different doses of PERT will be evaluated for improving fat and nitrogen absorption in infants with CF.

Key facts

Study ID
NCT01424696
Run by
Seattle Children's Hospital
People needed
231
Starts
2011-12-01
Expected to finish
2015-04-01
Last updated by the study team
2015-09-28

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.